<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01741129</url>
  </required_header>
  <id_info>
    <org_study_id>ZTB2611</org_study_id>
    <nct_id>NCT01741129</nct_id>
  </id_info>
  <brief_title>Comparison of Effectiveness of Nasal CPAP and Nasal IMV in Early Rescue Surfactant Treatment in Preterm Infants</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mehmet Yekta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zekai Tahir Burak Women's Health Research and Education Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aimed to compare the efficacy of nasal intermittent mandatory ventilation
      (IMV) and nasal continuous positive airway pressure (CPAP) in early rescue surfactant
      treatment in preterm infants.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">September 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of nasal intermittent mandatory ventilation (IMV) and nasal continuous positive airway pressure (CPAP) in early rescue surfactant treatment in preterm infants</measure>
    <time_frame>3 months</time_frame>
    <description>If infants needed invasive MV or Required a fraction of inspired oxygen of &gt;40% to maintain the targeted saturation of &gt;88% to 92%, surfactant treatment will give for respiratory distress syndrome (RDS). It means that nasal IMV or CPAP is ineffective.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complications of respiratory support</measure>
    <time_frame>3 months</time_frame>
    <description>respiratory insufficiency, pneumothorax</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Noninvasive Ventilation for Respiratory Distress Syndrome</condition>
  <arm_group>
    <arm_group_label>Nasal Continuous Positive Airway Pressure (CPAP)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After 2 hours evaluation:
Infants needed invasive MV (mechanic ventilation) or Required a fraction of inspired oxygen of &gt;40% to maintain the targeted saturation of &gt;88% to 92%.
Non-invasive surfactant treatment (Curosurf®) 100 mg/kg per dose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nasal Intermittent Mandatory Ventilation (IMV)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After 2 hours evaluation:
Infants needed invasive MV or Required a fraction of inspired oxygen of &gt;40% to maintain the targeted saturation of &gt; 88% to 92%.
Non-invasive surfactant treatment (Curosurf®) 100 mg/kg per dose</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nasal CPAP (SLE)</intervention_name>
    <description>PEEP: 4-6 cmH2O, Flow: 8 to 10 L/minute</description>
    <arm_group_label>Nasal Continuous Positive Airway Pressure (CPAP)</arm_group_label>
    <other_name>SLE 2000, SLE 5000</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nasal IMV (SLE)</intervention_name>
    <description>PIP: 15-20 cmH2O, PEEP: 4-6 cmH2O, Inspiratory time: 0.4-0.5 second, Rate: 20-30 /minute</description>
    <arm_group_label>Nasal Intermittent Mandatory Ventilation (IMV)</arm_group_label>
    <other_name>SLE 2000, SLE 5000</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Gestational age 26-32 weeks

        The criteria for failure were met by at least 1 of the following:

          -  pH: 7.10 and PaCO2: 70 mm Hg

          -  Recurrent apnea with &gt;3 episodes (Prophylactic caffeine were used in all infants)

          -  Single episode of apnea that required bag-and-mask ventilation

          -  PaO2: 50 mmHg with a fraction of inspired oxygen of &gt;0.5.

        Exclusion Criteria:

          -  Major congenital anomalies

          -  Presence of cardiovascular instability

          -  Intubation at admission to the NICU

          -  Consent not provided or refused
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>2 Hours</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Zekai Tahir Burak Maternity Teaching Hospital</name>
      <address>
        <city>Ankara</city>
        <zip>06230</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 26, 2012</study_first_submitted>
  <study_first_submitted_qc>November 29, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2012</study_first_posted>
  <last_update_submitted>March 7, 2014</last_update_submitted>
  <last_update_submitted_qc>March 7, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 10, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Zekai Tahir Burak Women's Health Research and Education Hospital</investigator_affiliation>
    <investigator_full_name>Mehmet Yekta</investigator_full_name>
    <investigator_title>Zekai Tahir Burak Maternity and Teaching Hospital, Ankara</investigator_title>
  </responsible_party>
  <keyword>Nasal CPAP</keyword>
  <keyword>Nasal IMV</keyword>
  <keyword>Surfactant</keyword>
  <keyword>Preterm infants</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Surfactants</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

